{"id":"NCT00069641","sponsor":"Shire","briefTitle":"Iduronate-2-sulfatase Enzyme Replacement Therapy in Mucopolysaccharidosis II (MPS II)","officialTitle":"A Phase II/III, Randomized, Double-Blind, Placebo-Controlled Study Evaluating the Safety and Efficacy of Weekly and Every Other Week Dosing Regimens of Iduronate-2-Sulfatase Enzyme Replacement Therapy in Patients With MPS II","status":"COMPLETED","phase":"PHASE2","dates":{"start":"2003-09-18","primaryCompletion":"2005-03-16","completion":"2005-03-16","firstPosted":"2003-10-01","resultsPosted":"2015-05-13","lastUpdate":"2021-06-10"},"enrollment":96,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"DOUBLE","primaryPurpose":"TREATMENT"},"conditions":["Mucopolysaccharidosis II"],"interventions":[{"type":"BIOLOGICAL","name":"Iduronate-2-sulfatase enzyme replacement therapy","otherNames":["Elaprase"]},{"type":"BIOLOGICAL","name":"iduronate-2-sulfatase enzyme replacement therapy","otherNames":["Elaprase"]},{"type":"BIOLOGICAL","name":"Placebo","otherNames":[]}],"arms":[{"label":"Idursulfase weekly (0.5 mg/kg)","type":"EXPERIMENTAL"},{"label":"Idursulfase every other week (0.5 mg/kg)","type":"EXPERIMENTAL"},{"label":"Placebo","type":"PLACEBO_COMPARATOR"}],"summary":"The purpose of this study is to determine whether the administration of iduronate-2-sulfatase enzyme in a weekly or every other week therapy frequency is safe and efficacious in patients with MPS II.","primaryOutcome":{"measure":"Ranked Adjusted 2-Component Composite Variable Score Based on Change From Baseline to Week 53","timeFrame":"Baseline, Week 53","effectByArm":[{"arm":"Idursulfase Weekly (0.5 mg/kg)","deltaMin":69.81,"sd":7.03},{"arm":"Placebo","deltaMin":50.86,"sd":8.07}],"pValues":[{"comp":"OG000 vs OG001","p":"0.0049"}]},"eligibility":{"minAge":"5 Years","sex":"MALE","healthyVolunteers":false,"inclusionCount":null,"exclusionCount":null},"locations":{"siteCount":9,"countries":["United States","Brazil","Germany","United Kingdom"]},"refs":{"pmids":["33874971","23837440"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":9,"n":32},"commonTop":["Pyrexia","Headache","Cough","Vomiting nos","Nasal congestion"]}}